The novel SLASH score showed superior performance to the SLAC score for predicting 6-month atrial fibrillation recurrence following electrical cardioversion.
Does the SLASH score improve prediction of 6-month AF recurrence in patients undergoing electrical cardioversion compared to the SLAC score?
The novel SLASH score outperforms the existing SLAC score in predicting 6-month atrial fibrillation recurrence following electrical cardioversion, potentially improving risk stratification.
Absolute Event Rate: 0% vs 0%
The SLAC score provides moderate prediction of 6-month AF recurrence after ECV. The SLASH score showed superior performance and may improve risk stratification and rhythm management. Prospective validation is warranted.
Thangjui et al. (Mon,) reported a other. The novel SLASH score showed superior performance to the SLAC score for predicting 6-month atrial fibrillation recurrence following electrical cardioversion.